Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer

Conditions

• Urothelial Carcinoma Bladder

Interventions

• DRUG: Sasanlimab
• RADIATION: Stereotactic Body Radiation Therapy
• PROCEDURE: Radical Cystectomy + pelvic lymph node dissection + urinary diversion

Sponsor

The Methodist Hospital Research Institute

Collaborators

• [object Object]